Submitted:
12 June 2025
Posted:
12 June 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
-
Eligibility Criteria
- Study design: Original articles including case studies, observational studies and randomized trials.
- Method: Studies that involved performing the sentinel node mapping using V-NOTES technique.
- Human involvement.
- Language: Studies published in English.
- Full text availability.
- Information Sources and Search Strategy
- Study Selection
- Data Extraction
3. Results
3.1. Characteristics of the Studies Included
3.2. Characteristics of the Population Included
3.3. Histological and Imaging Characteristics
3.4. Surgical Outcomes
3.5. SNL Mapping Outcomes
3.6. Complications and Follow-Up
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
Abbreviations
| V-NOTES | Vaginal Natural Orifice Transluminal Endoscopic Surgery |
| SLN | Sentinel Lymph Node |
| ICG | Indocyanine green |
References
- Rahib, L.; Smith, B.D.; Aizenberg, R.; Rosenzweig, A.B.; Fleshman, J.M.; Matrisian, L.M. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Research 2014, 74, 2913–2921. [Google Scholar] [CrossRef] [PubMed]
- Oaknin, A.; Bosse, T.J.; Creutzberg, C.L.; Giornelli, G.; Harter, P.; Joly, F.; Lorusso, D.; Marth, C.; Makker, V.; Mirza, M.R.; et al. Endometrial Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up. Annals of Oncology 2022, 33, 860–877. [Google Scholar] [CrossRef]
- Holloway, R.W.; Abu-Rustum, N.R.; Backes, F.J.; Boggess, J.F.; Gotlieb, W.H.; Jeffrey Lowery, W.; Rossi, E.C.; Tanner, E.J.; Wolsky, R.J. Sentinel Lymph Node Mapping and Staging in Endometrial Cancer: A Society of Gynecologic Oncology Literature Review with Consensus Recommendations. Gynecologic Oncology 2017, 146, 405–415. [Google Scholar] [CrossRef]
- Todo, Y.; Kato, H.; Kaneuchi, M.; Watari, H.; Takeda, M.; Sakuragi, N. Survival Effect of Para-Aortic Lymphadenectomy in Endometrial Cancer (SEPAL Study): A Retrospective Cohort Analysis. The Lancet 2010, 375, 1165–1172. [Google Scholar] [CrossRef]
- Mariani, A.; Dowdy, S.C.; Cliby, W.A.; Gostout, B.S.; Jones, M.B.; Wilson, T.O.; Podratz, K.C. Prospective Assessment of Lymphatic Dissemination in Endometrial Cancer: A Paradigm Shift in Surgical Staging. Gynecologic Oncology 2008, 109, 11–18. [Google Scholar] [CrossRef]
- Ducie, J.A.; Eriksson, A.G.Z.; Ali, N.; McGree, M.E.; Weaver, A.L.; Bogani, G.; Cliby, W.A.; Dowdy, S.C.; Bakkum-Gamez, J.N.; Soslow, R.A.; et al. Comparison of a Sentinel Lymph Node Mapping Algorithm and Comprehensive Lymphadenectomy in the Detection of Stage IIIC Endometrial Carcinoma at Higher Risk for Nodal Disease. Gynecologic Oncology 2017, 147, 541–548. [Google Scholar] [CrossRef]
- El-Ghobashy, A.E.; Saidi, S.A. Sentinel Lymph Node Sampling in Gynaecological Cancers: Techniques and Clinical Applications. European Journal of Surgical Oncology (EJSO) 2009, 35, 675–685. [Google Scholar] [CrossRef]
- Khoury-Collado, F.; Abu-Rustum, N.R. Lymphatic Mapping in Endometrial Cancer: A Literature Review of Current Techniques and Results. International Journal of Gynecological Cancer 2008, 18, 1163–1168. [Google Scholar] [CrossRef]
- Concin, N.; Matias-Guiu, X.; Vergote, I.; Cibula, D.; Mirza, M.R.; Marnitz, S.; Ledermann, J.; Bosse, T.; Chargari, C.; Fagotti, A.; et al. ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma. International Journal of Gynecological Cancer 2021, 31, 12–39. [Google Scholar] [CrossRef]
- Ferro, R.; Hurni, Y.; Seidler, S.; Huber, D. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Gynecological Emergencies. European Journal of Obstetrics & Gynecology and Reproductive Biology: X 2023, 20, 100261. [Google Scholar] [CrossRef]
- Li, C.; Hua, K. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) in Gynecologic Surgeries: A Systematic Review. Asian Journal of Surgery 2020, 43, 44–51. [Google Scholar] [CrossRef] [PubMed]
- Bouchez, M.-C.; Delporte, V.; Delplanque, S.; Leroy, M.; Vandendriessche, D.; Rubod, C.; Cosson, M.; Giraudet, G. vNOTES Hysterectomy: What about Obese Patients? Journal of Minimally Invasive Gynecology 2023, 30, 569–575. [Google Scholar] [CrossRef] [PubMed]
- Leblanc, E.; Narducci, F.; Bresson, L.; Hudry, D. Fluorescence-Assisted Sentinel (SND) and Pelvic Node Dissections by Single-Port Transvaginal Laparoscopic Surgery, for the Management of an Endometrial Carcinoma (EC) in an Elderly Obese Patient. Gynecologic Oncology 2016, 143, 686–687. [Google Scholar] [CrossRef] [PubMed]
- Baekelandt, J.F. New Retroperitoneal Transvaginal Natural Orifice Transluminal Endoscopic Surgery Approach to Sentinel Node for Endometrial Cancer: A Demonstration Video. Journal of Minimally Invasive Gynecology 2019, 26, 1231–1232. [Google Scholar] [CrossRef]
- Baekelandt, J.; Jespers, A.; Huber, D.; Badiglian-Filho, L.; Stuart, A.; Chuang, L.; Ali, O.; Burnett, A. vNOTES Retroperitoneal Sentinel Lymph Node Dissection for Endometrial Cancer Staging: First Multicenter, Prospective Case Series. Acta Obstet Gynecol Scand 2024, 103, 1311–1317. [Google Scholar] [CrossRef]
- Comba, C.; Karakas, S.; Erdogan, S.V.; Demir, O.; Şimşek, E.; Karasabanoglu, F.; Demirayak, G.; Ozdemir, I.A. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (VNOTES) Retroperitoneal Sentinel Lymph Node BIOPSY Compared with Conventional Laparoscopy in Patients with Endometrial Cancer. Surgical Oncology 2024, 55, 102099. [Google Scholar] [CrossRef]
- Comba, C.; Demirayak, G.; Simsek, C.; Atas, B.S.; Özdemir, İ.A. Transvaginal Natural Orifice Transluminal Endoscopic Surgery (VNOTES) Total Retroperitoneal Sentinel Lymph Node Biopsy for an Endometrial Cancer Patient with Prior Colon Cancer Surgery. International Journal of Gynecological Cancer 2021, 31, 1386–1387. [Google Scholar] [CrossRef]
- Deng, L.; Liu, Y.; Yao, Y.; Deng, Y.; Tang, S.; Sun, L.; Wang, Y. Efficacy of Vaginal Natural Orifice Transluminal Endoscopic Sentinel Lymph Node Biopsy for Endometrial Cancer: A Prospective Multicenter Cohort Study. International Journal of Surgery 2023. [Google Scholar] [CrossRef]
- Huber, D.; Hurni, Y. Sentinel Node Biopsy for Endometrial Cancer by Retroperitoneal Transvaginal Natural Orifice Transluminal Endoscopic Surgery: A Preliminary Study. Front. Surg. 2022, 9, 907548. [Google Scholar] [CrossRef]
- Huber, D.; Hurni, Y. Anatomical Distribution of Sentinel Lymph Nodes Harvested by Retroperitoneal vNOTES in 34 Consecutive Patients With Early-Stage Endometrial Cancer: Analysis of 124 Lymph Nodes. Journal of Minimally Invasive Gynecology 2024, 31, 438–444. [Google Scholar] [CrossRef]
- Lee, C.-L.; Liu, H.-M.; Khan, S.; Lee, P.-S.; Huang, K.-G.; Yen, C.-F. Vaginal Natural Orifice Transvaginal Endoscopic Surgery (vNOTES) Surgical Staging for Endometrial Carcinoma: The Feasibility of an Innovative Approach. Taiwanese Journal of Obstetrics and Gynecology 2022, 61, 345–352. [Google Scholar] [CrossRef] [PubMed]
- Matak, L.; Šimičević, M.; Dukić, B.; Matak, M.; Baekelandt, J. vNOTES Surgical Staging for Endometrial Carcinoma in Overweight Patients: A Case Series. Arch Gynecol Obstet 2024, 309, 2829–2832. [Google Scholar] [CrossRef] [PubMed]
- Mathey, M.-P.; Romito, F.; Huber, D.E. Retroperitoneal Sentinel Lymph Node Biopsy by Vaginally Assisted Natural Orifices Endoscopic Transluminal Endoscopic Surgery in Early Stage Endometrial Cancer: Description of Technique and Surgeon’s Perspectives after the First Experience. Case Rep Oncol 2022, 15, 291–299. [Google Scholar] [CrossRef] [PubMed]
- Şimşek, E.; Yıldız, Ö.A.; Gündüz, S.; Karakaş, S.; Yaşar, L. vNOTES Scarless and Painless Endometrial Cancer Staging Surgery. J of Obstet and Gynaecol 2024, 50, 1965–1970. [Google Scholar] [CrossRef]
- Tantitamit, T.; Lee, C.-L. Application of Sentinel Lymph Node Technique to Transvaginal Natural Orifices Transluminal Endoscopic Surgery in Endometrial Cancer. Journal of Minimally Invasive Gynecology 2019, 26, 949–953. [Google Scholar] [CrossRef]
- Wang, Y.; Deng, L.; Tang, S.; Dou, Y.; Yao, Y.; Li, Y.; Deng, Y.; Chen, Y.; Liang, Z. vNOTES Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Description of Technique and Perioperative Outcomes. Journal of Minimally Invasive Gynecology 2021, 28, 1254–1261. [Google Scholar] [CrossRef]
- Onstad, M.A.; Schmandt, R.E.; Lu, K.H. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. JCO 2016, 34, 4225–4230. [Google Scholar] [CrossRef]
- Wang, F.; Liu, Y.; Xing, Y.; Wang, D.; Bai, X.; Li, L.; Ma, C.; Sun, Y.; Bai, Y.; Wang, L. Clinical Efficacy and Safety Study of vNOTES for Benign Ovarian Tumors in Obese Patients. Sci Rep 2025, 15, 4609. [Google Scholar] [CrossRef]
- Kapurubandara, S.; Lowenstein, L.; Salvay, H.; Herijgers, A.; King, J.; Baekelandt, J. Consensus on Safe Implementation of Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES). European Journal of Obstetrics & Gynecology and Reproductive Biology 2021, 263, 216–222. [Google Scholar] [CrossRef]
- Marchand, G.J.; Masoud, A.T.; Ulibarri, H.; Arroyo, A.; Moir, C.; Blanco, M.; Herrera, D.G.; Hamilton, B.; Ruffley, K.; Petersen, M.; et al. Systematic Review and Meta-Analysis of Vaginal Natural Orifice Transluminal Endoscopic Surgery vs Laparoscopic Hysterectomy. AJOG Global Reports 2024, 4, 100320. [Google Scholar] [CrossRef]
- Hurni, Y.; Romito, F.; Huber, D. Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Surgical Staging of Early-Stage Ovarian Cancers: A Report of Two Cases. Front. Surg. 2022, 9, 833126. [Google Scholar] [CrossRef] [PubMed]
- Kellerhals, G.; Nef, J.; Hurni, Y.; Huber, D. Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Early-Stage Ovarian Cancer and Borderline Ovarian Tumors: A Case Series. Front. Surg. 2025, 12, 1542486. [Google Scholar] [CrossRef] [PubMed]
- Hurni, Y.; Huber, D.E. Sentinel Node Biopsy by Transvaginal Natural Orifice Transluminal Endoscopic Surgery in a Patient with Early-Stage Cervical Cancer: A Case Report. Case Rep Oncol 2022, 15, 547–552. [Google Scholar] [CrossRef]
- Restaino, S.; Buda, A.; Puppo, A.; Capozzi, V.A.; Sozzi, G.; Casarin, J.; Gallitelli, V.; Murgia, F.; Vizzielli, G.; Baroni, A.; et al. Anatomical Distribution of Sentinel Lymph Nodes in Patients with Endometrial Cancer: A Multicenter Study. International Journal of Gynecological Cancer 2022, 32, 517–524. [Google Scholar] [CrossRef]
- Sozzi, G.; Fanfani, F.; Berretta, R.; Capozzi, V.A.; Uccella, S.; Buono, N.; Giallombardo, V.; Di Donna, M.C.; Monterossi, G.; Restaino, S.; et al. Laparoscopic Sentinel Node Mapping with Intracervical Indocyanine Green Injection for Endometrial Cancer: The SENTIFAIL Study – a Multicentric Analysis of Predictors of Failed Mapping. International Journal of Gynecological Cancer 2020, 30, 1713–1718. [Google Scholar] [CrossRef]
- Laufer, J.; Scasso, S.; Papadia, A. Different Tracers for Sentinel Node Detection in Gynecologic Oncology. Current Opinion in Oncology 2024, 36, 371–375. [Google Scholar] [CrossRef]
- Hou, Q.; Li, X.; Li, Y.; Zhang, Q.; Liu, T.; Huang, L.; Gong, Z.; Feng, D.; Gu, D.; Lin, Y.; et al. Analysis and Suggestions on the Complications in 2000 Cases of Transvaginal Natural Orifice Transluminal Endoscopic Surgery: Can It Be a Conventional Surgery? Intl J Gynecology & Obste 2024, 164, 541–549. [Google Scholar] [CrossRef]
- DeNardis, S.A.; Holloway, R.W.; Bigsby, G.E.; Pikaart, D.P.; Ahmad, S.; Finkler, N.J. Robotically Assisted Laparoscopic Hysterectomy versus Total Abdominal Hysterectomy and Lymphadenectomy for Endometrial Cancer. Gynecologic Oncology 2008, 111, 412–417. [Google Scholar] [CrossRef]
- Kaya, A.C.; Radosa, M.P.; Zimmermann, J.S.M.; Stotz, L.; Findeklee, S.; Hamza, A.; Sklavounos, P.; Takacs, F.Z.; Wagenpfeil, G.; Radosa, C.G.; et al. Intraoperative and Postoperative Complications of Gynecological Laparoscopic Interventions: Incidence and Risk Factors. Arch Gynecol Obstet 2021, 304, 1259–1269. [Google Scholar] [CrossRef]

| Author | Year | Design | Patients | Mean age | Mean BMI (kg/m2) | > 25 kg/m2 (%) | Mean parity | Prior surgery (%) |
| Baekeland [15] | 2024 | Case series | 64 | 69.5 | 26 | 34 | - | 38 |
| Comba [16] | 2024 | Cohort | 19 | 59.4 | 29 | 100 | 2 | - |
| Comba [17] | 2021 | Case report | 1 | 46 | 27.4 | 100 | 2 | 100 |
| Deng [18] | 2023 | Cohort | 57 | 51.46 | 26.25 | 78.95 | 2 | 31.58 |
| Huber [19] | 2022 | Case series | 7 | 68 | 26.4 | 57 | 2.2 | 57 |
| Huber [20] | 2024 | Case series | 34 | 68 | 27.3 | - | - | 58.8 |
| Lee [21] | 2022 | Case series | 15 | 52.8 | 27.8 | 26 | 1.8 | 26 |
| Matak [22] | 2024 | Case series | 4 | 67 | 28.45 | 100 | 2 | 25 |
| Mathey [23] | 2022 | Case report | 1 | 64 | - | - | - | - |
| Simsek [24] | 2024 | Case series | 24 | 56.5 | 31 | - | - | 67 |
| Tantitamit [25] | 2018 | Case series | 4 | 60.3 | 25.6 | 75 | 3.2 | 50 |
| Wang [26] | 2021 | Cohort | 23 | 53 | 24.2 | - | 2 | 34 |
| Author | Year | Tumor histology |
Tumor grading | Imaging (US/MRI) | Staging |
| Baekeland [15] | 2024 | All types and Complex Atypical Hyperplasia | 1-3 | No | I-II |
| Comba [16] | 2024 | - | - | Yes | - |
| Comba [17] | 2021 | Endometrioid | 2 | Yes | I |
| Deng [18] | 2023 | Endometrioid | - | Yes | I |
| Huber [19] | 2022 | Endometrioid and Complex Atypical Hyperplasia | 1-2 | Yes | I |
| Huber [20] | 2024 | Endometrioid and Complex Atypical Hyperplasia | - | Yes | I |
| Lee [21] | 2022 | Endometrioid | 1-2 | Yes | I |
| Matak [22] | 2024 | Endometrioid | 1 | No | I |
| Mathey [23] | 2022 | Endometrioid | 1 | Yes | I |
| Simsek [24] | 2024 | - | - | Yes | - |
| Tantitamit [25] | 2018 | - | - | No | I |
| Wang [26] | 2021 | Endometrioid | 1-2 | Yes | I |
| Author | Year | SLN approach | Tracer | Mean op. Time | Estimated blood loss (ml) | Pre-op-Post-op HB (g/dl) |
| Baekeland [15] | 2024 | Retroperitoneal | ICG | 126 | 80 | -1 |
| Comba [16] | 2024 | Retroperitoneal | ICG | 208.4 | 76.3 | -1.5 |
| Comba [17] | 2021 | Retroperitoneal | ICG | 180 | 20 | - |
| Deng [18] | 2023 | Transperitoneal | ICG, CNP | 132.35 | 75 | - |
| Huber [19] | 2022 | Retroperitoneal | ICG | 113 | 20 | - |
| Huber [20] | 2024 | Retroperitoneal | ICG | - | - | - |
| Lee [21] | 2022 | Transperitoneal | ICG | 231.4 | 122 | -1.44 |
| Matak [22] | 2024 | Retroperitoneal | ICG | 169 | - | -1.9 |
| Mathey [23] | 2022 | Retroperitoneal | ICG | 113 | 100 | - |
| Simsek [24] | 2024 | Retroperitoneal | ICG | 125 | 70 | - |
| Tantitamit [25] | 2018 | Transperitoneal | ICG | 182.7 | 67 | -0.57 |
| Wang [26] | 2021 | Transperitoneal | CNP | 132.3 | 90 | -1 |
| Author | Year | Succes rate (%) | Total LN | Mean Right LN | Mean Left LN | Overall DR (%) | Bilateral DR (%) | Unilateral DR (%) |
| Baekeland [15] | 2024 | 98.5 | 3 | - | - | 100 | 97 | 3 |
| Comba [16] | 2024 | 94.8 | - | - | - | 94.8 | - | - |
| Comba [17] | 2021 | 100 | - | - | - | 100 | - | - |
| Deng [18] | 2023 | 81.5 | - | - | - | 94.7 | 82.4 | 12.3 |
| Huber [19] | 2022 | 100 | 3.1 | 1.2 | 1.8 | 100 | 100 | - |
| Huber [20] | 2024 | 91.2 | 3 | 1 | 1 | 97.1 | 91.2 | 5.9 |
| Lee [21] | 2022 | 100 | 5.3 | 2.3 | 1.9 | 100 | - | - |
| Matak [22] | 2024 | 100 | 12.5 | 5.7 | 6.2 | 100 | - | - |
| Mathey [23] | 2022 | 100 | 3 | 1 | 2 | 100 | 100 | - |
| Simsek [24] | 2024 | 96 | 2 | 1 | 1 | 96 | 91 | 4 |
| Tantitamit [25] | 2018 | 100 | 8.5 | 5 | 2.5 | 100 | 100 | - |
| Wang [26] | 2021 | 95.7 | 5 | - | - | 95.7 | 87 | 8.7 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).